BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. have entered into a new merger agreement under which a subsidiary of BioSante will merge into ANI. BioSante will issue to ANI stockholders shares of BioSante stock under which former ANI stockholders will own 57% of the combined company’s shares, and the former BioSante stockholders will own 43%.   Prior to the merger, BioSante will distribute contingent value rights (CVRs) providing payment rights from future sales, transfer, license ...